This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Microcap Article: Archive
2 Small Caps: Do You Bet on the Horse or the Jockey?
by Mark Zinski
Here we highlight two small caps for investors looking for either the strong thoroughbred or the savvy jockey.
TSSIPositive Net Change KFSPositive Net Change
artificial-intelligence small-cap
Zacks Initiates Coverage of Kingsway Financial With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates Kingsway Financial as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore KFS' strategic growth initiatives and financial health amid market challenges.
KFSPositive Net Change
insurance
AXR Stock Flat Despite Q1 Earnings Surge, Improvement in Revenues
by Zacks Equity Research
AMREP's overall top line benefits from growth in all the revenue sources.
AXRPositive Net Change
earnings real-estate
Value Line's Q1 Earnings Increase Y/Y on EAM Growth
by Zacks Equity Research
VALU posted a 21% increase in Q1 net income, fueled by a 48% surge in EAM-related revenue and strong investment gains. Shareholders' equity also rose 3.4% during the quarter.
VALUNegative Net Change
earnings finance
EVI Industries Q4 Earnings Rise Y/Y on Strong Parts and Services Growth
by Zacks Equity Research
EVI reports a 7.7% EPS increase in Q4 2024 despite a 4% drop in revenues, supported by higher-margin parts and services, along with improved gross margins.
EVIPositive Net Change
earnings industrial-products
Zacks Initiates Coverage of TSS With Outperform Recommendation
by Urbashi Dutta
Discover why Zacks rates TSSI as "Outperform," being the first on Wall Street to initiate the coverage of the stock. Explore how TSS is well-positioned for long-term success in the data center market despite customer concentration risks and rising inventory.
TSSIPositive Net Change
industrial-products
Zacks Initiates Coverage of Healthcare Triangle With Underperform Recommendation
by Debanjana Dey
Discover why Zacks rates Healthcare Triangle as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore HCTI's heavy reliance on top clients amid liquidity issues and ongoing losses.
HCTINegative Net Change
medical medical-devices
Perma-Pipe's Q2 Earnings Soar Y/Y on Strong MENA Demand
by Zacks Equity Research
PPIH reports a robust Q2 with earnings per share jumping to 40 cents, and a 7% rise in sales driven by a growing backlog.
PPIHPositive Net Change
earnings industrial-products
MIND Technology Q2 Loss Narrows Y/Y, Seamap Demand Drives Growth
by Zacks Equity Research
MIND incurred a net loss per share of 11 cents in the second quarter of fiscal 2025, narrowed from the prior-year quarter, with revenues rising to $10 million, reflecting operational improvements and strong Seamap demand.
MINDNegative Net Change
business-services earnings
Kewaunee Scientific's Earnings and Sales Decline Y/Y in Q1
by Zacks Equity Research
Delays in international shipments, especially in India due to customer construction site issues, impact KEQU's Q1 earnings.
KEQUPositive Net Change
earnings tech-stocks
Frequency Electronics Q1 Earnings Rise Y/Y on Satellite Payload Growth
by Zacks Equity Research
FEIM reports a strong Q1 for fiscal 2025, with EPS and revenues rising 14% and 22%, respectively. Growth in satellite payloads and improved margins offset a dip in government sales.
FEIMPositive Net Change
computers earnings tech-stocks
HURC Stock Up Despite Y/Y Decline in Q3 Earnings, Gross Margin Down
by Zacks Equity Research
Hurco's overall topline is dampened by revenue declines in all its geographic regions.
HURCPositive Net Change
earnings industrial-products
September Sell-Side and Buy-Side Consensus at a Glance
by John Blank
"Bottoms-up" consensus on EPS growth for S&P500 stocks? Outside consensus expects +15.3% in 2025, +10.1% in 2024.
asset-allocation
Zacks September View on Equity Markets
by John Blank
The Zacks Conglomerates sector in the USA looks like an interesting area to be selectively invested in currently.
asset-allocation
September Asset Allocation Guidelines
by John Blank
The latest Sept. 4th, 2024 data shows indexes with style upside. Highest returns come with the large cap growth indices.
asset-allocation
ZRS Chart of the Month
by John Blank
Early autumn ranks showed two Very Attractive sectors: Industrials and Utilities.
asset-allocation
International: Update on Global Regions
by John Blank
Certain global events can have a material effect on S&P 500 companies and overall index performance.
asset-allocation
Pro-Dex Q4 Earnings Rise Y/Y, Sales Surge on Customer Growth
by Zacks Equity Research
PDEX sees EPS rise to 46 cents in fiscal Q4 alongside a 41% surge in sales to $15 million, fueled by strategic operational efficiencies and key customer growth.
PDEXPositive Net Change
earnings medical
Zacks Initiates Coverage of Precipio With Outperform Recommendation
by Debanjana Dey
Discover why Zacks rates Precipio as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore PRPO's approaching breakeven milestones, financial health, and market positioning in the cancer diagnostics space.
PRPONegative Net Change
cancer medical
SigmaTron Incurs Q4 Loss, Revenues Drop on Weak Demand
by Zacks Equity Research
SGMA incurs a fiscal Q4 loss as revenues fall 25% due to reduced demand and supply chain issues. Cost-cutting measures and loan renegotiations aim to stabilize operations.
SGMANegative Net Change
computers earnings tech-stocks
Zacks August View on Equity Markets
by John Blank
Houses Sold has gone sideways for seven years. Meanwhile Houses for Sale have expanded dramatically. Where does this noted imbalance go from here?
asset-allocation
August Asset Allocation Guidelines
by John Blank
5 different frameworks specify portfolio risk tolerance: from Risky "Max Growth" to Conservative "Income." Choose one that fits you.
asset-allocation
ZRS Chart of the Month
by John Blank
Info Tech is overpriced, at rich valuations. An excess valuation remains obvious. That is the "AI" froth factor. Factor in the tech mega-caps too.
asset-allocation
Sell-Side and Buy-Side Consensus at a Glance
by John Blank
A valuation boost from the attraction of a broad equity risk premium looks OK using Zacks 2024 S&P500 earnings of $241.53.
asset-allocation
International: Update on Global Regions
by John Blank
Many U.S. corporations have a global presence, with assets and revenues in or from foreign countries. Therefore, certain global events can have a material effect on S&P 500 companies and overall index performance.
asset-allocation